메뉴 건너뛰기




Volumn 10, Issue 4, 2015, Pages 589-601

In vivo evaluation of paclitaxel-loaded lipid nanocapsules after intravenous and oral administration on resistant tumor

Author keywords

cancer; nanoparticles; oral route; paclitaxel; pharmacodynamics; pharmacokinetics; rats

Indexed keywords

1,2 DISTEAROYL SN GLYCERO 3 PHOSPHOETHANOLAMINE N [AMINO(POLYETHYLENE GLYCOL)]; CHITOSAN; LIPID NANOCAPSULE; MACROGOL DERIVATIVE; NANOCAPSULE; PACLITAXEL; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; PHOSPHATIDYLETHANOLAMINE; POLYETHYLENE GLYCOL-DISTEAROYLPHOSPHATIDYLETHANOLAMINE;

EID: 84924192226     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.14.124     Document Type: Article
Times cited : (41)

References (56)
  • 1
    • 41949119102 scopus 로고    scopus 로고
    • Paclitaxel and docetaxel resistance: Molecular mechanisms and development of new generation taxanes
    • Galletti E, Magnani M, Renzulli ML, Botta M. Paclitaxel and docetaxel resistance: molecular mechanisms and development of new generation taxanes. Chem Med Chem 2(7), 920-942 (2007).
    • (2007) Chem Med Chem , vol.2 , Issue.7 , pp. 920-942
    • Galletti, E.1    Magnani, M.2    Renzulli, M.L.3    Botta, M.4
  • 2
    • 84872288933 scopus 로고    scopus 로고
    • Update on taxane development: New analogs and new formulations
    • Yared JA, Tkaczuk KH. Update on taxane development: new analogs and new formulations. Drug Des. Devel. Ther. 6, 371-384 (2012).
    • (2012) Drug Des. Devel. Ther. , vol.6 , pp. 371-384
    • Yared, J.A.1    Tkaczuk, K.H.2
  • 3
    • 0034880214 scopus 로고    scopus 로고
    • Cremophor EL: The drawbacks and advantages of vehicle selection for drug formulation
    • Gelderblom H, Verweij J, Nooter K, Sparreboom A. Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation. Eur. J. Cancer 37(13), 1590-1598 (2001).
    • (2001) Eur. J. Cancer , vol.37 , Issue.13 , pp. 1590-1598
    • Gelderblom, H.1    Verweij, J.2    Nooter, K.3    Sparreboom, A.4
  • 4
    • 68949199436 scopus 로고    scopus 로고
    • The adaptation of lipid nanocapsule formulations for blood administration in animals
    • Hureaux J, Lagarce F, Gagnadoux F, Clavreul A, Benoit JP, Urban T. The adaptation of lipid nanocapsule formulations for blood administration in animals. Int. J. Pharm 379(2), 266-269 (2009).
    • (2009) Int. J. Pharm , vol.379 , Issue.2 , pp. 266-269
    • Hureaux, J.1    Lagarce, F.2    Gagnadoux, F.3    Clavreul, A.4    Benoit, J.P.5    Urban, T.6
  • 5
    • 33745386420 scopus 로고    scopus 로고
    • Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules
    • Peltier S, Oger JM, Lagarce F, Couet W, Benoit JP. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules. Pharm. Res. 23(6), 1243-1250 (2006).
    • (2006) Pharm. Res. , vol.23 , Issue.6 , pp. 1243-1250
    • Peltier, S.1    Oger, J.M.2    Lagarce, F.3    Couet, W.4    Benoit, J.P.5
  • 6
    • 84881182067 scopus 로고    scopus 로고
    • Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide
    • Saliou B, Thomas O, Lautram N et al. Development and in vitro evaluation of a novel lipid nanocapsule formulation of etoposide. Eur. J. Pharm. Sci. 50(2), 172-180 (2013).
    • (2013) Eur. J. Pharm. Sci. , vol.50 , Issue.2 , pp. 172-180
    • Saliou, B.1    Thomas, O.2    Lautram, N.3
  • 7
    • 84865282526 scopus 로고    scopus 로고
    • Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride
    • Vrignaud S, Hureaux J, Wack S, Benoit J-P, Saulnier P. Design, optimization and in vitro evaluation of reverse micelle-loaded lipid nanocarriers containing erlotinib hydrochloride. Int. J. Pharm. 436(1-2), 194-200 (2012).
    • (2012) Int. J. Pharm. , vol.436 , Issue.1-2 , pp. 194-200
    • Vrignaud, S.1    Hureaux, J.2    Wack, S.3    Benoit, J.-P.4    Saulnier, P.5
  • 8
    • 78751705543 scopus 로고    scopus 로고
    • Tumor transfection after systemic injection of DNA lipid nanocapsules
    • Morille M, Passirani C, Dufort S et al. Tumor transfection after systemic injection of DNA lipid nanocapsules. Biomaterials 32(9), 2327-2333 (2011).
    • (2011) Biomaterials , vol.32 , Issue.9 , pp. 2327-2333
    • Morille, M.1    Passirani, C.2    Dufort, S.3
  • 9
    • 84884156153 scopus 로고    scopus 로고
    • EGFR siRNA lipid nanocapsules effciently transfect glioma cells in vitro
    • Resnier P, David S, Lautram N et al. EGFR siRNA lipid nanocapsules effciently transfect glioma cells in vitro. Int. J. Pharm. 454(2), 748-755 (2013).
    • (2013) Int. J. Pharm. , vol.454 , Issue.2 , pp. 748-755
    • Resnier, P.1    David, S.2    Lautram, N.3
  • 10
    • 77949274490 scopus 로고    scopus 로고
    • Toxicological study and effcacy of blank and paclitaxel-loaded lipid nanocapsules after i.V. Administration in mice
    • Hureaux J, Lagarce F, Gagnadoux F et al. Toxicological study and effcacy of blank and paclitaxel-loaded lipid nanocapsules after i.v. administration in mice. Pharm. Res. 27(3), 421-430 (2010).
    • (2010) Pharm. Res. , vol.27 , Issue.3 , pp. 421-430
    • Hureaux, J.1    Lagarce, F.2    Gagnadoux, F.3
  • 11
    • 68949218775 scopus 로고    scopus 로고
    • The gastrointestinal stability of lipid nanocapsules
    • Roger E, Lagarce F, Benoit JP. The gastrointestinal stability of lipid nanocapsules. Int. J. Pharm. 379(2), 260-265 (2009).
    • (2009) Int. J. Pharm. , vol.379 , Issue.2 , pp. 260-265
    • Roger, E.1    Lagarce, F.2    Benoit, J.P.3
  • 12
    • 84887371418 scopus 로고    scopus 로고
    • Fate of Paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery
    • Groo a-C, Saulnier P, Gimel J-C et al. Fate of Paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery. Int. J. Nanomed. 8(1), 4291-4302 (2013).
    • (2013) Int. J. Nanomed. , vol.8 , Issue.1 , pp. 4291-4302
    • Groo, A.-C.1    Saulnier, P.2    Gimel, J.-C.3
  • 13
    • 70350617685 scopus 로고    scopus 로고
    • Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis
    • Roger E, Lagarce F, Garcion E, Benoit JP. Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J. Control. Release 140(2), 174-181 (2009).
    • (2009) J. Control. Release , vol.140 , Issue.2 , pp. 174-181
    • Roger, E.1    Lagarce, F.2    Garcion, E.3    Benoit, J.P.4
  • 14
    • 33748313404 scopus 로고    scopus 로고
    • A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats
    • Garcion E, Lamprecht A, Heurtault B et al. A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats. Mol. Cancer Ther. 5(7), 1710-1722 (2006).
    • (2006) Mol. Cancer Ther. , vol.5 , Issue.7 , pp. 1710-1722
    • Garcion, E.1    Lamprecht, A.2    Heurtault, B.3
  • 15
    • 12644278301 scopus 로고    scopus 로고
    • Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
    • Sparreboom A, Van Asperen J, Mayer U et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. Proc. Natl Acad. Sci. USA 94(5), 2031-2035 (1997).
    • (1997) Proc. Natl Acad. Sci. USA , vol.94 , Issue.5 , pp. 2031-2035
    • Sparreboom, A.1    Van Asperen, J.2    Mayer, U.3
  • 16
    • 77953917000 scopus 로고    scopus 로고
    • Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells
    • Roger E, Lagarce F, Garcion E, Benoit JP. Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells. Eur. J. Pharm. Sci. 40(5), 422-429 (2010).
    • (2010) Eur. J. Pharm. Sci. , vol.40 , Issue.5 , pp. 422-429
    • Roger, E.1    Lagarce, F.2    Garcion, E.3    Benoit, J.P.4
  • 17
    • 0036297426 scopus 로고    scopus 로고
    • A novel phase inversion-based process for the preparation of lipid nanocarriers
    • Heurtault B, Saulnier P, Pech B, Proust JE, Benoit JP. A novel phase inversion-based process for the preparation of lipid nanocarriers. Pharm Res. 19(6), 875-880 (2002).
    • (2002) Pharm Res. , vol.19 , Issue.6 , pp. 875-880
    • Heurtault, B.1    Saulnier, P.2    Pech, B.3    Proust, J.E.4    Benoit, J.P.5
  • 18
    • 70350244685 scopus 로고    scopus 로고
    • PLGA nanoparticles stabilized with cationic surfactant: Safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat
    • Bhardwaj V, Ankola DD, Gupta SC, Schneider M, Lehr CM, Kumar MNVR. PLGA nanoparticles stabilized with cationic surfactant: safety studies and application in oral delivery of paclitaxel to treat chemical-induced breast cancer in rat. Pharm. Res. 26(11), 2495-2503 (2009).
    • (2009) Pharm. Res. , vol.26 , Issue.11 , pp. 2495-2503
    • Bhardwaj, V.1    Ankola, D.D.2    Gupta, S.C.3    Schneider, M.4    Lehr, C.M.5    Kumar, M.N.V.R.6
  • 19
    • 77953360626 scopus 로고    scopus 로고
    • Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles
    • Agueros M, Zabaleta V, Espuelas S, Campanero MA, Irache JM. Increased oral bioavailability of paclitaxel by its encapsulation through complex formation with cyclodextrins in poly(anhydride) nanoparticles. J. Control. Release 145(1), 2-8 (2010).
    • (2010) J. Control. Release , vol.145 , Issue.1 , pp. 2-8
    • Agueros, M.1    Zabaleta, V.2    Espuelas, S.3    Campanero, M.A.4    Irache, J.M.5
  • 20
    • 77955294499 scopus 로고    scopus 로고
    • Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats
    • Jin J, Bi H, Hu J et al. Enhancement of oral bioavailability of paclitaxel after oral administration of Schisandrol B in rats. Biopharm. Drug Dispos. 31(4), 264-268 (2010).
    • (2010) Biopharm. Drug Dispos. , vol.31 , Issue.4 , pp. 264-268
    • Jin, J.1    Bi, H.2    Hu, J.3
  • 21
    • 79955522520 scopus 로고    scopus 로고
    • The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles
    • Mo R, Jin X, Li N et al. The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. Biomaterials 32(20), 4609-4620 (2011).
    • (2011) Biomaterials , vol.32 , Issue.20 , pp. 4609-4620
    • Mo, R.1    Jin, X.2    Li, N.3
  • 22
    • 78349308871 scopus 로고    scopus 로고
    • Development and in vivo evaluation of an oral drug delivery system for paclitaxel
    • Iqbal J, Sarti F, Perera G, Bernkop-Schnürch A. Development and in vivo evaluation of an oral drug delivery system for paclitaxel. Biomaterials 32(1), 170-175 (2011).
    • (2011) Biomaterials , vol.32 , Issue.1 , pp. 170-175
    • Iqbal, J.1    Sarti, F.2    Perera, G.3    Bernkop-Schnürch, A.4
  • 23
    • 1242337284 scopus 로고    scopus 로고
    • Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors
    • Yang S, Gursoy RN, Lambert G, Benita S. Enhanced oral absorption of paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of P-glycoprotein inhibitors. Pharm. Res. 21(2), 261-270 (2004).
    • (2004) Pharm. Res. , vol.21 , Issue.2 , pp. 261-270
    • Yang, S.1    Gursoy, R.N.2    Lambert, G.3    Benita, S.4
  • 24
    • 84883582500 scopus 로고    scopus 로고
    • Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin e succinate nanomicelles based on a mucus bioadhesion and penetration mechanism
    • Lian H, Zhang T, Sun J et al. Enhanced oral delivery of paclitaxel using acetylcysteine functionalized chitosan-vitamin E succinate nanomicelles based on a mucus bioadhesion and penetration mechanism. Mol. Pharm. 10 (9), 3447-3458 (2013).
    • (2013) Mol. Pharm. , vol.10 , Issue.9 , pp. 3447-3458
    • Lian, H.1    Zhang, T.2    Sun, J.3
  • 25
    • 84896724791 scopus 로고    scopus 로고
    • Enhanced oral bioavailability of paclitaxel by concomitant use of absorption enhancers and P-glycoprotein inhibitors in rats
    • Montaseri H, Mohammadi-Samani S, Zarea B, Sobhani Z, Ahmadi F. Enhanced oral bioavailability of paclitaxel by concomitant use of absorption enhancers and P-glycoprotein inhibitors in rats. J. Chemother. 25(6), 355-361 (2013).
    • (2013) J. Chemother. , vol.25 , Issue.6 , pp. 355-361
    • Montaseri, H.1    Mohammadi-Samani, S.2    Zarea, B.3    Sobhani, Z.4    Ahmadi, F.5
  • 26
    • 11144240987 scopus 로고    scopus 로고
    • The effect of verapamil on the pharmacokinetics of paclitaxel in rats
    • Choi JS, Li X. The effect of verapamil on the pharmacokinetics of paclitaxel in rats. Eur. J. Pharm. Sci. 24(1), 95-100 (2005).
    • (2005) Eur. J. Pharm. Sci. , vol.24 , Issue.1 , pp. 95-100
    • Choi, J.S.1    Li, X.2
  • 27
    • 84880079471 scopus 로고    scopus 로고
    • Carboxymethyl-chitosan-tethered lipid vesicles: Hybrid nanoblanket for oral delivery of paclitaxel
    • Joshi N, Saha R, Shanmugam T, Balakrishnan B, More P, Banerjee R. Carboxymethyl-chitosan-tethered lipid vesicles: hybrid nanoblanket for oral delivery of paclitaxel. Biomacromolecules 14(7), 2272-2282 (2013).
    • (2013) Biomacromolecules , vol.14 , Issue.7 , pp. 2272-2282
    • Joshi, N.1    Saha, R.2    Shanmugam, T.3    Balakrishnan, B.4    More, P.5    Banerjee, R.6
  • 28
    • 84864013044 scopus 로고    scopus 로고
    • Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel
    • Jain S, Kumar D, Swarnakar NK, Thanki K. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel. Biomaterials 33(28), 6758-6768 (2012).
    • (2012) Biomaterials , vol.33 , Issue.28 , pp. 6758-6768
    • Jain, S.1    Kumar, D.2    Swarnakar, N.K.3    Thanki, K.4
  • 29
    • 84863783683 scopus 로고    scopus 로고
    • Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: Permeability and pharmacokinetic study
    • Zabaleta V, Ponchel G, Salman H, Agueros M, Vauthier C, Irache JM. Oral administration of paclitaxel with pegylated poly(anhydride) nanoparticles: permeability and pharmacokinetic study. Eur. J. Pharm. Biopharm. 81(3), 514-523 (2012).
    • (2012) Eur. J. Pharm. Biopharm. , vol.81 , Issue.3 , pp. 514-523
    • Zabaleta, V.1    Ponchel, G.2    Salman, H.3    Agueros, M.4    Vauthier, C.5    Irache, J.M.6
  • 30
    • 77952996831 scopus 로고    scopus 로고
    • Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats
    • Lee CK, Choi JS. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats. Pharmacology 85(6), 350-356 (2010).
    • (2010) Pharmacology , vol.85 , Issue.6 , pp. 350-356
    • Lee, C.K.1    Choi, J.S.2
  • 31
    • 84855800458 scopus 로고    scopus 로고
    • Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats
    • Park JH, Hur HJ, Woo JS, Lee HJ. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats. Eur. J. Pharm. Sci. 45(3), 296-301 (2012).
    • (2012) Eur. J. Pharm. Sci. , vol.45 , Issue.3 , pp. 296-301
    • Park, J.H.1    Hur, H.J.2    Woo, J.S.3    Lee, H.J.4
  • 32
    • 40449086665 scopus 로고    scopus 로고
    • Dose translation from animal to human studies revisited
    • Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 22(3), 659-661 (2008).
    • (2008) FASEB J. , vol.22 , Issue.3 , pp. 659-661
    • Reagan-Shaw, S.1    Nihal, M.2    Ahmad, N.3
  • 34
    • 0036554742 scopus 로고    scopus 로고
    • Infuence of Cremophor El on the bioavailability of intraperitoneal paclitaxel
    • Gelderblom H, Verweij J, Van Zomeren DM et al. Infuence of Cremophor El on the bioavailability of intraperitoneal paclitaxel. Clin. Cancer Res. 8(4), 1237-1241 (2002).
    • (2002) Clin. Cancer Res. , vol.8 , Issue.4 , pp. 1237-1241
    • Gelderblom, H.1    Verweij, J.2    Van Zomeren, D.M.3
  • 37
    • 33646389800 scopus 로고    scopus 로고
    • Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors
    • Khalid MN, Simard P, Hoarau D, Dragomir A, Leroux JC. Long circulating poly(ethylene glycol)-decorated lipid nanocapsules deliver docetaxel to solid tumors. Pharm. Res. 23(4), 752-758 (2006).
    • (2006) Pharm. Res. , vol.23 , Issue.4 , pp. 752-758
    • Khalid, M.N.1    Simard, P.2    Hoarau, D.3    Dragomir, A.4    Leroux, J.C.5
  • 39
    • 70350728656 scopus 로고    scopus 로고
    • Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting
    • Morille M, Montier T, Legras P et al. Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting. Biomaterials 31(2), 321-329 (2010).
    • (2010) Biomaterials , vol.31 , Issue.2 , pp. 321-329
    • Morille, M.1    Montier, T.2    Legras, P.3
  • 40
    • 84866484085 scopus 로고    scopus 로고
    • Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-beta-cyclodextrin as an oral delivery system
    • Baek JS, So JW, Shin SC, Cho CW. Solid lipid nanoparticles of paclitaxel strengthened by hydroxypropyl-beta-cyclodextrin as an oral delivery system. Int. J. Mol. Med. 30(4), 953-959 (2012).
    • (2012) Int. J. Mol. Med. , vol.30 , Issue.4 , pp. 953-959
    • Baek, J.S.1    So, J.W.2    Shin, S.C.3    Cho, C.W.4
  • 41
    • 45549094992 scopus 로고    scopus 로고
    • Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients
    • Chu Z, Chen J-S, Liau C-T et al. Oral bioavailability of a novel paclitaxel formulation (Genetaxyl) administered with cyclosporin A in cancer patients. Anticancer Drugs 19(3), 275-281 (2008).
    • (2008) Anticancer Drugs , vol.19 , Issue.3 , pp. 275-281
    • Chu, Z.1    Chen, J.-S.2    Liau, C.-T.3
  • 42
    • 84904267805 scopus 로고    scopus 로고
    • Development of 2D and 3D mucus models and their interactions with mucus penetrating paclitaxel loaded lipid nanocapsules
    • Groo a-C, Mircheva K, Bejaud J et al. Development of 2D and 3D mucus models and their interactions with mucus penetrating paclitaxel loaded lipid nanocapsules. Pharm. Res.31(7), 1753-1765 (2014).
    • (2014) Pharm. Res. , vol.31 , Issue.7 , pp. 1753-1765
    • Groo, A.-C.1    Mircheva, K.2    Bejaud, J.3
  • 43
    • 0001583660 scopus 로고    scopus 로고
    • Coadministration of oral cyclosporin a enables oral therapy with paclitaxel
    • Meerum Terwogt JM, Malingré MM, Beijnen JH et al. Coadministration of oral cyclosporin a enables oral therapy with paclitaxel. Clin. Cancer Res. 5(11), 3379-3384 (1999).
    • (1999) Clin. Cancer Res. , vol.5 , Issue.11 , pp. 3379-3384
    • Meerum Terwogt, J.M.1    Malingré, M.M.2    Beijnen, J.H.3
  • 44
    • 33644922361 scopus 로고    scopus 로고
    • Effcacy and mechanism of action of chitosan nanocapsules for oral peptide delivery
    • Prego C, Fabre M, Torres D, Alonso MJ. Effcacy and mechanism of action of chitosan nanocapsules for oral peptide delivery. Pharm. Res. 23(3), 549-556 (2006).
    • (2006) Pharm. Res. , vol.23 , Issue.3 , pp. 549-556
    • Prego, C.1    Fabre, M.2    Torres, D.3    Alonso, M.J.4
  • 45
    • 84855435709 scopus 로고    scopus 로고
    • Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles
    • Siew A, Le H, Thiovolet M, Gellert P, Schatzlein A, Uchegbu I. Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles. Mol. Pharm. 9(1), 14-28 (2011).
    • (2011) Mol. Pharm. , vol.9 , Issue.1 , pp. 14-28
    • Siew, A.1    Le Thiovolet H, M.2    Gellert, P.3    Schatzlein, A.4    Uchegbu, I.5
  • 46
    • 79955032379 scopus 로고    scopus 로고
    • Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles
    • Chakravarthi SS, Robinson DH. Enhanced cellular association of paclitaxel delivered in chitosan-PLGA particles. Int. J. Pharm. 409(1-2), 111-120 (2011).
    • (2011) Int. J. Pharm. , vol.409 , Issue.1-2 , pp. 111-120
    • Chakravarthi, S.S.1    Robinson, D.H.2
  • 47
    • 78149342494 scopus 로고    scopus 로고
    • Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system
    • Li H, Huo M, Zhou J et al. Enhanced oral absorption of paclitaxel in N-deoxycholic acid-N, O-hydroxyethyl chitosan micellar system. J. Pharm. Sci. 99(11), 4543-4553 (2010).
    • (2010) J. Pharm. Sci. , vol.99 , Issue.11 , pp. 4543-4553
    • Li, H.1    Huo, M.2    Zhou, J.3
  • 48
    • 79959868168 scopus 로고    scopus 로고
    • Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus
    • Lai Sk, Suk Js, Pace A et al. Drug carrier nanoparticles that penetrate human chronic rhinosinusitis mucus. Biomaterials 32(26), 6285-6290 (2011).
    • (2011) Biomaterials , vol.32 , Issue.26 , pp. 6285-6290
    • Sk, L.1    Js, S.2    Pace, A.3
  • 49
    • 57049085726 scopus 로고    scopus 로고
    • Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier
    • Wang YY, Lai SK, Suk JS, Pace A, Cone R, Hanes J. Addressing the PEG mucoadhesivity paradox to engineer nanoparticles that "slip" through the human mucus barrier. Angew. Chem. Int. Ed. 47(50), 9726-9729 (2008).
    • (2008) Angew. Chem. Int. Ed. , vol.47 , Issue.50 , pp. 9726-9729
    • Wang, Y.Y.1    Lai, S.K.2    Suk, J.S.3    Pace, A.4    Cone, R.5    Hanes, J.6
  • 50
    • 84857363579 scopus 로고    scopus 로고
    • A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles
    • Mert O, Lai SK, Ensign L et al. A poly(ethylene glycol)-based surfactant for formulation of drug-loaded mucus penetrating particles. J. Control. Release 157(3), 455-460 (2012).
    • (2012) J. Control. Release , vol.157 , Issue.3 , pp. 455-460
    • Mert, O.1    Lai, S.K.2    Ensign, L.3
  • 51
    • 84877920679 scopus 로고    scopus 로고
    • Mucopenetrating nanoparticles: Vehicles for the oral administration of paclitaxel
    • Zabaleta V, Calleja P, Espuelas S et al. Mucopenetrating nanoparticles: vehicles for the oral administration of paclitaxel. Ann. Pharm. Fr. 71(2), 109-118 (2013).
    • (2013) Ann. Pharm. Fr. , vol.71 , Issue.2 , pp. 109-118
    • Zabaleta, V.1    Calleja, P.2    Espuelas, S.3
  • 53
    • 35448936022 scopus 로고    scopus 로고
    • Enhancement of cisplatin effcacy by thalidomide in a 9L rat gliosarcoma model
    • Murphy S, Davey RA, Gu XQ et al. Enhancement of cisplatin effcacy by thalidomide in a 9L rat gliosarcoma model. J. Neurooncol. 85(2), 181-189 (2007).
    • (2007) J. Neurooncol. , vol.85 , Issue.2 , pp. 181-189
    • Murphy, S.1    Davey, R.A.2    Gu, X.Q.3
  • 54
    • 34648831611 scopus 로고    scopus 로고
    • In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel
    • Lacoeuille F, Hindre F, Moal F et al. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int. J. Pharm. 344(1-2), 143-149 (2007).
    • (2007) Int. J. Pharm. , vol.344 , Issue.1-2 , pp. 143-149
    • Lacoeuille, F.1    Hindre, F.2    Moal, F.3
  • 55
    • 77952491719 scopus 로고    scopus 로고
    • Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery
    • Roger E, Lagarce F, Garcion E, Benoit JP. Biopharmaceutical parameters to consider in order to alter the fate of nanocarriers after oral delivery. Nanomedicine (London) 5(2), 287-306 (2010).
    • (2010) Nanomedicine (London) , vol.5 , Issue.2 , pp. 287-306
    • Roger, E.1    Lagarce, F.2    Garcion, E.3    Benoit, J.P.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.